Home/Filings/4/0001144204-19-017748
4//SEC Filing

Lopatin Uri A 4

Accession 0001144204-19-017748

CIK 0001426800other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:36 PM ET

Size

8.5 KB

Accession

0001144204-19-017748

Insider Transaction Report

Form 4
Period: 2019-03-29
Lopatin Uri A
Chief Med. Off., VP Res. Dev.
Transactions
  • Award

    Common Stock

    2019-03-29+13,750627,361 total
  • Award

    Stock Option (right to buy)

    2019-03-29+27,50027,500 total
    Exercise: $19.69Exp: 2029-03-29Common Stock (27,500 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    5,000
Footnotes (3)
  • [F1]Grant of restricted stock units. The restricted stock units vest in four equal installments, assuming continuous service on each vesting date, as follows: March 29, 2020; March 29, 2021; March 29, 2022; and March 29, 2023.
  • [F2]Total includes 606,111 shares that are held by the Uri Lopatin Revocable Trust for which the reporting person is the trustee and sole beneficiary. Accordingly, these shares are reported as being held directly by the reporting person.
  • [F3]Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% shall vest on the first anniversary of the date of grant, March 29, 2020; and the remaining 75% shall vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2023.

Issuer

ASSEMBLY BIOSCIENCES, INC.

CIK 0001426800

Entity typeother

Related Parties

1
  • filerCIK 0001613259

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:36 PM ET
Size
8.5 KB